More on screening mammography [2]

New England Journal of Medicine

Volumn 364, Issue 3, 2011, Pages 283-

  Fletcher, Suzanne W ^a   Elmore, Joann G ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER IMMUNIZATION; CANCER SCREENING; CANCER THERAPY; CASE CONTROL STUDY; HUMAN; LETTER; PRIORITY JOURNAL; TESTIS CANCER; UNITED KINGDOM; BREAST TUMOR; EARLY DIAGNOSIS; FEMALE; MAMMOGRAPHY; MASS SCREENING; MORTALITY; NOTE; RADIOGRAPHY;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING;

EID: 78751635671     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Screening for testicular cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement draft. Rockville, MD: Agency for Healthcare Research and Quality, 2010. (http://www. uspreventiveservicestaskforce.org/uspstf/uspstest.htm.)
2. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomized controlled trial. Lancet 2006;368:2053-60. (Pubitemid 44855105)
3. Elmore JG, Reisch LM, Barton MB, et al. Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst 2005;97:1035-43.